Search
for
Sort by
Research 481–510 of 1000+
- Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome (PCOS)
- 705 Influence of 5a-Reductase Inhibitor (5-ARI) Usage on the Reproductive Function of Married Men
- CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE
- Dermatological Maifestations of Obesity
- A review on Hair Loss & Damage
- Segmental cherry angiomas associated with extragenital lichen sclerosus: A report of two cases
- Reporting on Adverse Clinical Events
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- The human keratins: biology and pathology
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Polycystic ovary syndrome
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Polycystic ovary syndrome
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Use of chemotherapy during human pregnancy
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study<sup>1</sup>
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Environmental Factors and Puberty Timing: Expert Panel Research Needs
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair
- The Rotterdam Study: 2012 objectives and design update